| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |